Evidence map›Paper›PMID 36115223›Full record

ArticleDrug and alcohol dependence2022

Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples.

Ju Nyeong Park, Susan G Sherman, Victor Sigmund, Autumn Breaud, Kathryn Martin, William A Clarke

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A survey of North American drug checking services operating in 2022.The International journal on drug policy · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ju Nyeong ParkDivision of General Internal Medicine, Warren Alpert Medical School, United States; Department of Epidemiology, School of Public Health, Brown University, United States. Electronic address: ju_park@brown.edu.
Susan G ShermanDepartment of Health, Behavior and Society, Bloomberg School of Public Health, Johns Hopkins University, United States.
Victor SigmundDepartment of Health, Behavior and Society, Bloomberg School of Public Health, Johns Hopkins University, United States.
Autumn BreaudJohns Hopkins Advanced Clinical Chemistry Diagnostics Laboratory (ACCDL), Department of Pathology, The Johns Hopkins Hospital, United States.
Kathryn MartinJohns Hopkins Advanced Clinical Chemistry Diagnostics Laboratory (ACCDL), Department of Pathology, The Johns Hopkins Hospital, United States.
William A ClarkeJohns Hopkins Advanced Clinical Chemistry Diagnostics Laboratory (ACCDL), Department of Pathology, The Johns Hopkins Hospital, United States.
Johns Hopkins Hospital · USJohns Hopkins University · USJohn Brown University · US

Funding

Project 4: Neonatal Abstinence Syndrome (NAS): Fetus to First YearsP20GM125507 · NIGMS · RHODE ISLAND HOSPITAL · PI Ju Nyeong Park · 2018 to 2026
$23.4M
Detecting Illicit Fentanyl and its Analogues: a Validation StudyR03DA049998 · NIDA · JOHNS HOPKINS UNIVERSITY · PI SHERMAN, SUSAN G. · 2020 to 2021
$164k
NIDA NIH HHS R03 DA049998NIGMS NIH HHS P20 GM125507
6 · The paper itself

Abstract

backgroundDrug overdose deaths remain the primary cause of unintentional injuries in the United States. We examined the validity of a fentanyl test strip (FTS) in detecting fentanyl and its related analogs in water-based illicit drug solutions.

methodsIllicit drugs obtained from law enforcement (N = 343) were tested using a lateral flow chromatographic immunoassay FTS (BTNX Rapid Response) and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) at a clinical chemistry laboratory in Baltimore, Maryland.

resultsThe FTS assay detected fentanyl at 200 ng/ml in water, and 13 additional fentanyl analogs, but failed to detect carfentanil and furanyl fentanyl at or below 1000 ng/ml. Overall sensitivity and specificity for detecting fentanyls was 98.5 % and 89.2 %; and the false negative and positive rate was 1.5 % and 10.9 %. False negatives (n = 2) occurred in fentanyl and a fentanyl precursor. False positives (n = 23) occurred in the presence of other illicit drugs and compounds (56.5 %) or when fentanyls were present below 40 ng/ml (43.5 %). False positive/negative rates remained low when testing cocaine and prescription opioid (PO) samples.

conclusionsFTS is a valid drug checking tool, however, rapid immunoassays and other drug checking instruments that can detect a wider range of fentanyl analogs including carfentanil need to be prioritized to minimize accidental exposure to the full spectrum of fentanyls.

Indexed as

CocaineDrug OverdoseIllicit DrugsAnalgesics, OpioidChromatography, LiquidFentanylHumansImmunoassaySubstance Abuse DetectionTandem Mass SpectrometryUnited StatesWaterAnalgesics, OpioidCocaineFentanylIllicit DrugsWaterDrug testingHarm reductionOpioidsOverdoseSubstance use

Identifiers

PMID36115223
PMCPMC9588631
OpenAlexW4293764350

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.